Goldman Sachs’s Aceragen Inc ACGN Stock Holding History

Goldman Sachs’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-1,945	Closed	-$766K	–	7309
2014 Q2	$766K	Sell	1,945 -1,472	-43%	-$607K	﹤0.01%	4947
2014 Q1	$1.89M	Buy	+3,417	New	+$2.34M	﹤0.01%	4017

Other funds holding ACGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs's ACGN Position: Q4 2021 in Review

Goldman Sachs sold out of Aceragen Inc (ACGN) in Q4 2021, closing a stake of 2,316 shares — an estimated $41K sold.

Goldman Sachs first reported a position in ACGN in Q1 2014 and held it in 22 quarters. The position peaked at $1.18M in Q3 2015. 34 funds tracked by Wall St. Rank hold ACGN as of Q4 2021.

Goldman Sachs reported no remaining Aceragen Inc position as of Q4 2021 after selling out during the quarter.
Goldman Sachs sold 2,316 Aceragen Inc shares in Q4 2021, an estimated $41K.
Goldman Sachs first reported a position in Aceragen Inc in Q1 2014 and held it in 22 quarters.
Goldman Sachs's Aceragen Inc position peaked at $1.18M in Q3 2015.
34 funds tracked by Wall St. Rank held Aceragen Inc as of Q4 2021.

Based on Goldman Sachs's 13F filing for Q4 2021, filed 14 Feb 2022.